(2R,2R,Cis)-saxagliptin

CAS : 1564265-95-7

Ref. 3D-PMC26595

Informations sur le produit

• Nom: (2R,2R,Cis)-saxagliptin

Description

(2R,2R,Cis)-saxagliptin is an analytical research and development (R&D) drug development API impurity HPLC standard that is a metabolite of saxagliptin. Saxagliptin is a drug product that has been approved for the treatment of type 2 diabetes. It has been shown to inhibit the activity of dipeptidyl peptidase-4 (DPP-4) in vitro and in vivo. Saxagliptin is a competitive inhibitor of DPP-4, which prevents it from breaking down incretin hormones such as glucagon-like peptide 1 (GLP-1). This results in increased levels of GLP-1, which improves blood glucose control. The purity level for this API impurity HPLC standard is high. Impurities are less than 0.5% and have been tested at various concentrations to ensure quality standards are met.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 315.40 g/mol
• Formule: C₁₈H₂₅N₃O₂
• Degré de pureté: Min. 95%